7 Adjuvant and salvage irradiation following radical prostatectomy for prostate cancer
โ Scribed by M.M. Morris; K.C. Dallow; A.L. Zietman; A.F. Althausen; N.M. Heney; F.J. McGovern; W.U. Shipley
- Publisher
- Elsevier Science
- Year
- 1995
- Tongue
- English
- Weight
- 109 KB
- Volume
- 32
- Category
- Article
- ISSN
- 0360-3016
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Several randomized trials and a treatment guideline favor the use of adjuvant therapy for patients with adverse pathological features identified at radical prostatectomy. This study describes the variation in patterns of utilization and costs associated with these therapies.
## Abstract Despite the trend toward earlier diagnosis of adenocarcinoma of the prostate, approximately 25% of men undergoing radical prostatectomy will have pathologic evidence of cancer extending outside of the prostate. These patients are at high risk for subsequent recurrence. Such relapses are